NYSE ARCA | ETF
The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index.
The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies" products and services.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.42% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 2.17% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 2.02% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.00% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 1.93% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 1.93% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.93% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.80% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 1.78% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.78% |
| PKI | PerkinElmer Inc | Healthcare | Diagnostics & Research | 1.77% |
| AXGN | Axogen Inc | Healthcare | Medical Devices | 1.75% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 1.75% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 1.75% |
| DIA | DiaSorin S.p.A. | Healthcare | Diagnostics & Research | 1.71% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 1.66% |
| RVTY | Revvity Inc. | Healthcare | Diagnostics & Research | 1.62% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.61% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 1.61% |
| 6618 | Jd Health International Inc | Healthcare | Pharmaceutical Retailers | 1.61% |